NDC 85384-0023-01 - Tagrid Feminine Itch Relief Cream Antifungal Formula Clotrimazole 1%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85384-0023
- Requested NDC
- 85384-0023-01
- Package NDCs from labels
- 85384-0023-1, 85384-0023-01
- Manufacturer
- TAGRID LLC
- Effective date
- 2026-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLOTRIMAZOLE - TAGRID LLC | TAGRID LLC | 2026-05-15 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85384-0023-1 | Tagrid Feminine Itch Relief Cream Antifungal Formula Clotrimazole 1% | 56.7 g in 1 JAR | CREAM | 56.7 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a04af91-a708-6758-e053-2a95a90af152 | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a01551c-9bd4-2ab5-e053-2995a90aee99 | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a037129-9101-3253-e053-2a95a90ab5d2 | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a037f09-4092-714f-e053-2a95a90a52f6 | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a03e936-b01a-6dec-e053-2a95a90ad14a | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a03c1f7-098c-035d-e053-2a95a90a1fef | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a04509d-299b-fd96-e053-2995a90ad178 | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a03f62d-84c0-3e2c-e053-2995a90a6479 | 2025-01-09 | F84709P2XV | |
| Absinthium | ABSINTHIUM | Hahnemann Laboratories, Inc. | 9a01b9ec-c266-5ca8-e053-2995a90a0d0e | 2025-01-09 | F84709P2XV | |
| STERILE WATER | STERILE WATER | HF Acquisition Co. LLC, DBA HealthFirst | 74ed2a6f-824c-a1ff-e053-2a91aa0a57c0 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 77bd3c0f-f4ab-7cfa-e053-2a91aa0a1b83 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| ANTI-ITCH FEMININE CARE | HYDROCORTISONE 0.5% | OL PHARMA TECH, LLC Drs PHARMACY | d6fa5ff3-ebdc-222d-e053-2a95a90a88d5 | 2025-01-09 | Warnings | M005 |
| Clotrimazole | DRS. CLOTRIMAZOLE | OL PHARMA TECH,LLC | b0e9fc77-6d5c-2472-e053-2995a90a3de4 | 2025-01-09 | Warnings | M005 G07GZ97H65 |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Hemorrhoidal Cream with Aloe | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Chain Drug Marketing Association | 2b33c710-ac17-20f9-e063-6294a90ad29c | 2025-01-08 | Warnings | PDC6A3C0OX |
| ANTIBACTERIAL DREAMY FLORALS | GLYCERIN | Quimicas Handal de Centroamerica SA de CV | 09f73bec-516d-90f0-e063-6394a90aecab | 2025-01-08 | Warnings | PDC6A3C0OX |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.